Cutting-Edge Advances in Anticancer Therapies: Insights from the Third Edition of the Special Issue "Novel Anticancer Strategies"

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2025 Jan 25

PMID 39861702

Authors

Hassan Bousbaa

Affiliations

Soon will be listed here.

Abstract

Cancer incidence and mortality continue to rise at an alarming rate worldwide, underscoring the urgent need for more effective therapeutic interventions [...].

References

Wahnou H, Youlyouz-Marfak I, Liagre B, Sol V, Oudghiri M, Duval R . Shining a Light on Prostate Cancer: Photodynamic Therapy and Combination Approaches. Pharmaceutics. 2023; 15(6). PMC: 10302598. DOI: 10.3390/pharmaceutics15061767. View

Nkune N, Matlou G, Abrahamse H . Photodynamic Therapy Efficacy of Novel Zinc Phthalocyanine Tetra Sodium 2-Mercaptoacetate Combined with Cannabidiol on Metastatic Melanoma. Pharmaceutics. 2022; 14(11). PMC: 9695911. DOI: 10.3390/pharmaceutics14112418. View

Du Y, Luo L, Xu X, Yang X, Yang X, Xiong S . Unleashing the Power of Synthetic Lethality: Augmenting Treatment Efficacy through Synergistic Integration with Chemotherapy Drugs. Pharmaceutics. 2023; 15(10). PMC: 10610204. DOI: 10.3390/pharmaceutics15102433. View

Puiu R, Birca A, Grumezescu V, Duta L, Oprea O, Holban A . Multifunctional Polymeric Biodegradable and Biocompatible Coatings Based on Silver Nanoparticles: A Comparative In Vitro Study on Their Cytotoxicity towards Cancer and Normal Cell Lines of Cytostatic Drugs versus Essential-Oil-Loaded Nanoparticles.... Pharmaceutics. 2023; 15(7). PMC: 10385235. DOI: 10.3390/pharmaceutics15071882. View

Jampilek J, Kralova K . Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems. Pharmaceutics. 2022; 14(12). PMC: 9781429. DOI: 10.3390/pharmaceutics14122681. View

Gomes S, Baltazar F, Silva E, Preto A . Microbiota-Derived Short-Chain Fatty Acids: New Road in Colorectal Cancer Therapy. Pharmaceutics. 2022; 14(11). PMC: 9698921. DOI: 10.3390/pharmaceutics14112359. View

Cruz N, Herculano-Carvalho M, Roque D, Faria C, Cascao R, Ferreira H . Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma. Pharmaceutics. 2023; 15(3). PMC: 10054750. DOI: 10.3390/pharmaceutics15030928. View

Ristic B, Bosnjak M, Misirkic Marjanovic M, Stevanovic D, Janjetovic K, Harhaji-Trajkovic L . The Exploitation of Lysosomes in Cancer Therapy with Graphene-Based Nanomaterials. Pharmaceutics. 2023; 15(7). PMC: 10383369. DOI: 10.3390/pharmaceutics15071846. View

Toropko M, Chuvpilo S, Karabelsky A . miRNA-Mediated Mechanisms in the Generation of Effective and Safe Oncolytic Viruses. Pharmaceutics. 2024; 16(8). PMC: 11360794. DOI: 10.3390/pharmaceutics16080986. View

10.

Zhu L, Ma M, Zhang L, Wang S, Guo Y, Ling X . System Analysis Based on Lipid-Metabolism-Related Genes Identifies AGT as a Novel Therapy Target for Gastric Cancer with Neoadjuvant Chemotherapy. Pharmaceutics. 2023; 15(3). PMC: 10051152. DOI: 10.3390/pharmaceutics15030810. View

11.

Silva A, Felix A, Cerqueira M, Goncalves C, Sampaio-Marques B, Longatto-Filho A . Effects of Lactate Transport Inhibition by AZD3965 in Muscle-Invasive Urothelial Bladder Cancer. Pharmaceutics. 2023; 15(12). PMC: 10747642. DOI: 10.3390/pharmaceutics15122688. View

12.

Ali U, Bette M, Ambreen G, Pinnapireddy S, Tariq I, Marquardt A . RNAi-Mediated Knockdown of Cottontail Rabbit Papillomavirus Oncogenes Using Low-Toxicity Lipopolyplexes as a Paradigm to Treat Papillomavirus-Associated Cancers. Pharmaceutics. 2023; 15(10). PMC: 10610439. DOI: 10.3390/pharmaceutics15102379. View

13.

Mkhobongo B, Chandran R, Abrahamse H . In Vitro Photodynamic Treatment Modality for A375 Melanoma Cell Line Using a Sulphonated Aluminum Phthalocyanine Chloride-Photosensitizer-Gold Nanoparticle Conjugate. Pharmaceutics. 2022; 14(11). PMC: 9696044. DOI: 10.3390/pharmaceutics14112474. View

14.

Lee E, Lee E . Development of pH-Responsive Hyaluronic Acid-Conjugated Cyclodextrin Nanoparticles for Chemo-/CO-Gas Dual Therapy. Pharmaceutics. 2023; 15(7). PMC: 10384822. DOI: 10.3390/pharmaceutics15071818. View

15.

Egorova V, Kolesova E, Lopus M, Yan N, Parodi A, Zamyatnin Jr A . Smart Delivery Systems Responsive to Cathepsin B Activity for Cancer Treatment. Pharmaceutics. 2023; 15(7). PMC: 10386206. DOI: 10.3390/pharmaceutics15071848. View

16.

Leone G, Candido S, Lavoro A, Vivarelli S, Gattuso G, Calina D . Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer. Pharmaceutics. 2023; 15(4). PMC: 10142433. DOI: 10.3390/pharmaceutics15041252. View

17.

Hba S, Ghaddar S, Wahnou H, Pinon A, El Kebbaj R, Pouget C . Natural Chalcones and Derivatives in Colon Cancer: Pre-Clinical Challenges and the Promise of Chalcone-Based Nanoparticles. Pharmaceutics. 2023; 15(12). PMC: 10748144. DOI: 10.3390/pharmaceutics15122718. View

18.

Silva J, Pinto B, Monteiro L, Silva P, Bousbaa H . Combination Therapy as a Promising Way to Fight Oral Cancer. Pharmaceutics. 2023; 15(6). PMC: 10301495. DOI: 10.3390/pharmaceutics15061653. View

19.

Bousbaa H . Novel Anticancer Strategies II. Pharmaceutics. 2023; 15(2). PMC: 9959780. DOI: 10.3390/pharmaceutics15020605. View

20.

Luna-Gutierrez M, Hernandez-Ramirez R, Soto-Abundiz A, Garcia-Perez O, Ancira-Cortez A, Lopez-Buenrostro S . Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using Lu-iPSMA and Lu-DOTATOC: Experience after 905 Treatment Doses. Pharmaceutics. 2023; 15(7). PMC: 10386094. DOI: 10.3390/pharmaceutics15071988. View